CellSource Slashes Final Dividend as Full-Year Profit Slumps 74%

MT NewswiresDec 18 19:02

CellSource: Notice regarding dividends from surplus

JPXDec 18 16:00 · Announcements

Stocks that moved or were traded in the first half of the session.

*Needswell <3992> 377 - announced measures aimed at a stock price target of 600 yen. *Zojirushi Makino <7965> 1770 +202 raised its financial estimates, and operating profit is now projected to increase. *Park 24 <4666> 1994 +146.5 due to upward revisions from the previous term and a significant increase in dividend plans this term. *Mixi <2121> 3395 +235 expectations continue for the new SNS service. *Osaka Titanium Technologies <5726> 1766 +104 Bo.

Fisco JapanDec 17 12:57

Stocks that moved the day before part 1 INTLOOP, Sakura Saku, ANYCOLOR, ETC.

Stock name <code> Closing price on the 13th ⇒ Change from the previous day. Jellybeans <3070> 113 +5 announced a partial change (expansion) in the Shareholder preferential treatment system. Daiko Tsusan <7673> 1340 +101 upwardly revised the second quarter performance estimates. INTLOOP <9556> 6200 +790 the first quarter operating profit is 2.8 times higher than the same period last year. Spider Plus <4192> 384 +34 introduced a Shareholder preferential treatment system. Hatena <3930> 1000 +7625 performance estimates for the fiscal year ending July.

Fisco JapanDec 14 06:15

Rakusuru, Kamakura Shinsho, Oji HD, etc.

Seibu HD (9024) rose significantly by 89 to 3199. A basic agreement was signed regarding the liquidity of Tokyo Garden TELUS Kioicho, along with revisions to financial estimates and dividends, and the announcement of a share buyback. The operating profit estimate for the fiscal year ending March 2025 has been raised from the previous estimate of 45 billion yen to 289 billion yen, and the annual dividend has also been increased from the previously planned 30 yen to 40 yen. Additionally, a share buyback of 28 million shares, accounting for 8.66% of the issued shares, with a maximum limit of 70 billion yen was announced. The direction is considered priced in, focusing on shareholder returns.

Fisco JapanDec 13 15:06

Cell Source - Significant drop, viewed negatively due to performance landing below expectations in the previous period.

Cellsource <4880> has significantly declined. The company announced its financial results for the fiscal year ending October 2024 the previous day. The operating profit is 0.13 billion yen, a decrease of 89.4% compared to the previous period, which is significantly below the previous estimate of 0.42 billion yen. Regarding the contract services for processing synovial-derived stem cells, it has been determined that achieving the anticipated sales is difficult, and a provision for a contract loss of 273 million yen has been recorded. From the fiscal year ending October 2025, the company will transition to consolidated financial statements, and an operating profit of 0.37 billion yen is expected, but there is concern about the failure to meet the previous period's performance.

Fisco JapanDec 13 12:30